透過您的圖書館登入
IP:18.117.101.130
  • 期刊
  • OpenAccess

Rituximab-Related Interstitial Pneumonitis: A Case Report, the CT Images, and a Literature Review

摘要


Rituximab has been proved effective in B-cell lymphomas as a single agent or in combination with chemotherapy. In rare cases, it may cause interstitial lung disease due to potentially fatal pulmonary toxicity. We report a patient who developed severe interstitial pneumonitis after combination of rituximab with cyclophosphamide, vincristine and prednisolone (COP).

延伸閱讀